Investigation of the mechanisms involved in the central effects of glucagon-like peptide-1 on ethanol-induced gastric mucosal lesions

Regulatory Peptides

Volumn 128, Issue 1, 2005, Pages 57-62

  Isbil Buyukcoskun, Naciye ^a   Gulec, Guldal ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

Cholinergic system; Gastroprotection; Intracerebroventricular; Nitric oxide; Rat; Somatostatin

Indexed keywords

ALCOHOL; ATROPINE; ATROPINE METHYL NITRATE; GLUCAGON LIKE PEPTIDE 1; MECAMYLAMINE; MERCAPTAMINE; MUSCARINIC RECEPTOR BLOCKING AGENT; N(G) NITROARGININE METHYL ESTER; NICOTINIC RECEPTOR BLOCKING AGENT; NITRIC OXIDE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANNULA; DECAPITATION; DRUG EFFECT; DRUG MECHANISM; FEMALE; NONHUMAN; PRIORITY JOURNAL; RAT; STOMACH ULCER;

EID: 13844272414     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2004.12.019     Document Type: Article

References (41)

1. D.J. Drucker Biological actions and therapeutic potential of the glucagon-like peptides Gastroenterology 122 2002 531 544
2. C. Orskov, J.J. Holst, S. Knuhtsen, F.G. Baldissera, S.S. Poulsen, and O.V. Nielson Glucagon-like peptides GLP-1 and GLP-2, predicted products of the glucagon gene are secreted separately from the pig small intestine but not pancreas Endocrinology 119 1986 1467 1475
3. H.C. Fehmann, and J.F. Habener Insulinotropic glucagon-like peptide-1 (7-37)/(7-36) amide: a new incretin hormone Trends Endocrinol. Metab. 3 1992 158 163
4. B. Kreymann, G. Williams, M.A. Ghatei, and S.R. Bloom Glucagon-like peptide-1 (7-36): a physiological incretin in man Lancet 2 1987 1300 1304
5. P.J. Larsen, M. Tang-Christensen, J.J. Holst, and C. Orskov Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem Neuroscience 77 1997 257 270
6. J.M. Barragan, J. Eng, R. Rodriguez, and E. Blazquez Neural contribution to the effect of glucagon-like peptide-1-(7-36) amide on arterial blood pressure in rats Am. J. Physiol. 277 40 1999 E784 E791
7. N. Isbil-Buyukcoskun, and G. Gulec Effects of intracerebroventricularly injected glucagon-like peptide-1 on cardiovascular parameters; role of central cholinergic system and vasopressin Regul. Pept. 118 2004 33 38
8. S. Delgado-Aros, D.Y. Kim, D.D. Burton, G.M. Thomforde, D. Stephens, and B.H. Brinkmann Effect of GLP-1 on gastric volume, emptying, maximum volume ingested, and postprandial symptoms in humans Am. J. Physiol. 282 2002 G424 G431
9. N. Imeryuz, B.C. Yeǧen, A. Bozkurt, T. Coskun, M.L. Villanueva-Penacarrillo, and N.B. Ulusoy Glucagon-like peptide-1 inhibits gastric emptying via vagal afferent-mediated central mechanisms Am. J. Physiol. 273 4 1997 G920 G927
10. M.D. Turton, D.O. O'Shea, I. Gunn, S.A. Beak, C.M.B. Edwards, and K. Meeran A role for glucagon-like peptide-1 in the central regulation of feeding Nature 379 1996 69 72
11. 2: a physiological inhibitor of gastric acid secretion in man J. Endocrinol. 126 1990 169 173
12. W.J. Rossowski, B.L. Cheng, N.Y. Jiang, and D.H. Coy Examination of somatostatin involvement in the inhibitory action of GIP, GLP-1, amylin and adrenomedullin on gastric acid release using a new SRIF antagonist analogue Br. J. Pharmacol. 125 1998 1081 1087
13. N. Isbil-Buyukcoskun, and G. Gulec Effects of centrally injected GLP-1 in various experimental models of gastric mucosal damage Peptides 25 2004 1179 1183
14. G. Clementi, M. Amico-Roxas, A. Caruso, V.M.C. Cutuli, S. Maugeri, and A. Prato Protective effects of calcitonin gene-related peptide in different experimental models of gastric ulcers Eur. J. Pharmacol. 238 1993 101 104
15. F. Guidobono, F. Pagani, C. Ticozzi, V. Sibilia, A. Pecile, and C. Netti Protection by amylin of gastric erosions induced by indomethacin or ethanol in rats Br. J. Pharmacol. 120 1997 581 586
16. V. Sibilia, G. Rindi, F. Pagani, D. Rapetti, V. Locatelli, and A. Torsello Ghrelin protects against ethanol-induced gastric ulcers in rats: studies on the mechanisms of action Endocrinology 144 1 2003 353 359
17. S. Kawano, and S. Tsuji Role of mucosal blood flow: a conceptional review in gastric mucosal injury and protection J. Gastroenterol. Hepatol. 15 2000 D1 D6 [Suppl]
18. H. Matsuda, Y. Li, and M. Yoshikawa Gastroprotections of escins Ia, Ib, IIa, and IIb on ethanol-induced gastric mucosal lesions in rats Eur. J. Pharmacol. 373 1 1999 63 70
19. A. Tarnawski, D. Hollander, H. Gergely, and J. Stachura Comparison of antacid, sucralfate, cimetidine and ranitidine in protection of gastric mucosa against ethanol injury Gastroenterology 84 1983 1131
20. F. Guidobono, M. Coluzzi, F. Pagani, A. Pecile, and C. Netti Amylin given by central and peripheral routes inhibits acid gastric secretion Peptides 15 1994 699 702
21. G.E. Rovati, and S. Nicosia Lower efficacy: interaction with an inhibitory receptor or partial agonism? Trends Pharmacol. Sci. 15 1994 140 144
22. G. Clementi, A. Caruso, V.M.C. Cutuli, M.Z. Mangano, S. Salomone, and L. Lempereur Gastroprotective effect of adrenomedullin administered subcutaneously in the rat Peptides 23 2002 1149 1153
23. V. Pliska Models to explain dose-response relationships that exhibit a downturn phase Trends Pharmacol. Sci. 15 1994 178 181
24. Y. Wei, and S. Mojsov Tissue-specific expression of the human receptor for glucagon-like peptide-1: brain, heart and pancreatic forms have the same deduced amino acid sequences FEBS Lett. 358 1995 219 224
25. R. Goke, P.J. Larsen, J.D. Mikkelsen, and S.P. Sheikh Distribution of GLP-1 binding sites in the rat brain: evidence that exendin-4 is a ligand of brain GLP-1 binding sites Eur. J. Neurosci. 7 1995 2294 2300
26. D.J. Drucker, and S. Asa Glucagon gene expression in vertebrate brain J. Biol. Chem. 263 1988 13475 13478
27. S. Delgado-Aros, A. Vella, M. Camilleri, P.A. Low, D.D. Burton, and G.M. Thomforde Effects of glucagon-like peptide-1 feeding on gastric volumes in diabetes mellitus with cardio-vagal dysfunction Neurogastroenterol. Motil. 15 2003 435 443
28. T. Tolessa, E. Naslung, and P.M. Hellstrom The inhibitory mechanism of GLP-1, but not glucagon, on fasted gut motility is dependent on the l-arginine/nitric oxide pathway Regul. Pept. 98 2001 33 40
29. M. Giralt, and P. Vergara Sympathetic pathways mediate GLP-1 actions in the gastrointestinal tract of the rat Regul. Pept. 74 1998 19 25
30. R. Eissele, E. Bothe-Sandfort, B. Göke, J. Eng, R. Arnold, and H. Koop Rat gastric somatostatin and gastrin release: interaction of exendin-4 and truncated glucagon-like peptide-1 (GLP-1) amide Life Sci. 55 1994 629 634
31. A. Kiraly, G. Suto, and Y. Tache Role of nitric oxide in the gastric cytoprotection induced by central vagal stimulation Eur. J. Pharmacol. 240 1993 299 301
32. B.J.R. Whittle, J. Lopez-Belmonte, and S. Moncada Regulation of gastric mucosal integrity by endogenous nitric oxide: interactions with prostanoids and sensory neuropeptides in the rat Br. J. Pharmacol. 99 1990 607 611
33. K. Kato, H. Yang, and Y. Tache Low doses of TRH analogue act in the dorsal motor nucleus to induce gastric protection in rats Am. J. Physiol. 269 38 1995 R1301 R1307
34. E. Masuda, S. Kawano, K. Nagano, S. Tsuji, Y. Takei, and M. Tsujii Endogenous nitric oxide modulates ethanol-induced gastric mucosal injury in rats Gastroenterology 108 1995 58 64
35. E. Saperas, M. Mourelle, J. Santos, S. Moncada, and J.R. Malagelada Central vagal activation by an analogue of TRH stimulates gastric nitric oxide release in rats Am. J. Physiol. 268 31 1995 G895 G899
36. 2 release by central TRH in rats Am. J. Physiol. 264 27 1993 G231 G236
37. H. Ancha, H. Ojeas, D. Tedesco, A. Ward, and R.F. Harty Somatostatin-induced gastric protection against ethanol: involvement of nitric oxide and effects on gastric mucosal blood flow Regul. Pept. 110 2003 113 177
38. L. Dezsi, G. Dornyei, M. Szenlivanyi Jr., T. Tulassay, and E. Monos Somatostatin induces vasodilatation in the cat mesenteric artery via endothelium-derived nitric oxide and prostaglandins Pflugers Arch. 433 1997 536 538
39. M.R. Lucey, and T. Yamada Biochemistry and physiology of gastrointestinal somatostatin Dig. Dis. Sci. 34 1989 5S 13S
40. C. Orskov, J.J. Holst, and O.V. Nielsen Effect of truncated glucagon-like peptide-1 (proglucagon 78-107 amide) on endocrine secretion from pig pancreas, antrum, and stomach Endocrinology 123 1988 2009 2013
41. A. Wettergren, H. Petersen, J. Orskov, J. Christiansen, S.P. Sheikh, and J.J. Holst Glucagon-like peptide-1 (7-36) amide and peptide YY from L-cell of the ileal mucosa are potent inhibitors of vagally induced gastric acid secretion in man Scand. J. Gastroenterol. 29 1994 501 505